The list price of the therapy, Relyvrio, is much higher than an economic research group recommends, but the company says most patients will pay very little themselves.
from NYT > U.S. News https://ift.tt/lHoY0jC
Post Top Ad
Saturday, October 1, 2022
Price of New A.L.S. Treatment Will Be $158,000 Per Year, Maker Says
Tags
# NYT > U.S. News
About Unknown
Templatesyard is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of templatesyard is to provide the best quality blogger templates.
NYT > U.S. News
Labels:
NYT > U.S. News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment